Cargando…

Reduced EPO receptor expression may contribute to limited pleiotropic effects of EPO during critical illness

Detalles Bibliográficos
Autores principales:	McCook, O, Matějková, S, Matallo, J, Scheuerle, A, Moeller, P, Georgieff, M, Calzia, E, Radermacher, P, Schelzig, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363858/ http://dx.doi.org/10.1186/cc11047

Ejemplares similares

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Comparison of carbamylated versus recombinant erythropoietin during spinal cord ischemia/reperfusion injury
por: Simon, F, et al.
Publicado: (2010)

Erythropoietin in the critically ill: do we ask the right questions?
por: McCook, Oscar, et al.
Publicado: (2012)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

EPOS Abstract Book
Publicado: (2022)

Welcome to EPOS 2023
por: Sanpera, Ignacio, et al.
Publicado: (2023)

EPOS Abstract Book
Publicado: (2023)

Reduced expression of PPAR-β/δ limits the potential beneficial effects of GW0742 during septic shock in atherosclerotic swine
por: Bracht, H, et al.
Publicado: (2012)

How to pursue EPO in MS
por: Bartels, Claudia, et al.
Publicado: (2017)

Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients
por: Takasawa, Kazuya, et al.
Publicado: (2014)

An evaluation of the EPOS selective chemistry analyser
por: Hughes, G. J., et al.
Publicado: (1987)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

EPO pre-treatment for haemorrhagic shock
Publicado: (2013)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 33rd Annual Meeting
Publicado: (2014)

EPOS 35th Congress Meeting
Publicado: (2016)

EPOS 35th Congress Meeting
Publicado: (2016)

EPOS 35th Congress Meeting
Publicado: (2016)

EPOS 34th Annual Meeting
Publicado: (2015)

EPOS 34th Annual Meeting
Publicado: (2015)

EPOS 34th Annual Meeting
Publicado: (2015)

Author Index EPOS, 2015, France
Publicado: (2015)

Effect of intravenous H(2)S on porcine aortic occlusion-induced systemic inflammation and kidney ischemia/reperfusion injury
por: Wagner, F, et al.
Publicado: (2010)

Therapy of an incomplete spinal cord injury by intrathecal injection of EPO and subcutaneous injection of EPO, vitamin C and G-CSF
por: Bader, Augustinus, et al.
Publicado: (2017)

EPO‐receptor is present in mouse C2C12 and human primary skeletal muscle cells but EPO does not influence myogenesis
por: Lamon, Séverine, et al.
Publicado: (2014)

An evaluation of the Eppendorf EPOS 5060 biochemistry autoanalyser
por: Antoja, F., et al.
Publicado: (1987)

Potential of Novel EPO Derivatives in Limb Ischemia
por: Joshi, Dhiraj, et al.
Publicado: (2012)

Author Index EPOS, 2016, Rome, Italy
Publicado: (2016)

EPOS: EEG Processing Open-Source Scripts
por: Rodrigues, Johannes, et al.
Publicado: (2021)

The Effects of Curcumae Longae Radix, Curcuma phaeocaulis Radix and Their Processed Products on Epo/EpoR Pathway and CD62p
por: Chen, Zhimin, et al.
Publicado: (2018)

Local YB-1, Epo, and EpoR concentrations in fractured bones: results from a porcine model of multiple trauma
por: Bläsius, Felix Marius, et al.
Publicado: (2023)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Identification and single-base gene-editing functional validation of a cis-EPO variant as a genetic predictor for EPO-increasing therapies
por: Harlow, Charli E., et al.
Publicado: (2022)

Pre-emptive hypothermia during resuscitated porcine hemorrhagic shock
por: Matallo, J, et al.
Publicado: (2012)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

H(2)S in Critical Illness—A New Horizon for Sodium Thiosulfate?
por: Merz, Tamara, et al.
Publicado: (2022)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023)

EPO for stroke therapy - Is there a future for further clinical development?
por: Minnerup, Jens, et al.
Publicado: (2010)

Epo Receptors Are Not Detectable in Primary Human Tumor Tissue Samples
por: Elliott, Steve, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8mbit73tvhu2lhk8ijo82g64tq